🎤 Global Burden of Degenerative Mitral Regurgitation
BIG DATA
🫀The global prevalence of DMR has increased by 126% over a 30-year period - and now amounts to approximately 16 million people worldwide
🫀Prevalence is highest in the cohort aged 70-80 years
🎯There is a notable gender paradox - whilst DMR is more common in men, mortality is substantially higher (1.6-fold) in women years
🌍 And marked geographical disparity - with a 10-fold higher prevalence in high income countries
@crfheart@TCTConference@jgranadacrf
Presented at #TCT2026:
In a randomized trial, CCTA-guided PCI with structured preprocedural planning and intraprocedural guidance was noninferior to intravascular ultrasound–guided PCI with respect to target-vessel failure at 12 months. Full P4 trial results: nej.md/48jfVly@crfheart
ALT A graph from the Original Article "Coronary CT Angiography versus Intravascular Ultrasound Guidance for PCI." The trial name, P4, is in parentheses after the title. The graph shows the cumulative incidence of target-vessel failure (primary end point), defined as a composite of death from cardiac causes, target-vessel myocardial infarction, or ischemia-driven target-vessel revascularization, at 12 months. The trial results are being presented at the Transcatheter Cardiovascular Therapeutics 2026 Conference. The logo of the New England Journal of Medicine is at the bottom.
Terminado #SEC26@secardiologia congreso superado con éxito pese a las dificultades. Enhorabuena al comité organizador liderado por @MG_Crespo_Leiro y la indispensable colaboración del staff sec y del SOC asi como @tesec_eventos
🏆Galardonados por su excelencia como revisores de #recintervcardiol en 2026: Belén Cid | Alfonso Jurado-Román | Ander Regueiro | José R. Rumoroso | Pablo Salinas
#EliteReviewers
On my way to San Diego ✈️ for #TCT2026, the world's biggest gathering of interventional cardiology. Looking forward to sharing and learning with colleagues. See you there! 🫀@TCTConference@crfheart
📱 Install TAVRfy on your phone. It opens like an app and works offline.
iPhone (Safari): tavrfy.com → Share → Add to Home Screen
Android (Chrome): tavrfy.com → ⋮ menu → Install app
Free. No app store, no password.
TAVRfy.com a free educational tool to check sizing ranges of the main TAVR platforms.
· Data from manufacturers' IFUs and sizing guides, with sources.
· Sign in with your email
@shci_sec@PCRonline @EuroIntervention @TCTMD@TAVRBot
🔴 ¡Anunciamos el Track de IA en #SEC26!
Un programa de tres sesiones para explorar el impacto de la inteligencia artificial en cardiología, conocer experiencias de otros sectores y descubrir los proyectos del Hub IA de la SEC.
🗓️ 29 oct. | 17:45 h
Belén Cid, Lorenzo Fácila y Victoria Delgado abordarán el futuro de la IA en cardiología.
🗓️ 30 oct. | 09:00 h
Aitor Facio (Navantia), Julia Díaz (Repsol), M.ª Jesús Álvarez (Repsol) y Pablo Mateo (Proactivanet) compartirán experiencias de IA desde el ámbito empresarial.
🗓️ 31 oct. | 10:15 h
Jesús Jiménez, Marta Herrero y Andrea Guala presentarán proyectos del Hub IA relacionados con ECG, TAVI e imagen cardiaca.
📌 Tres sesiones para conocer las oportunidades y desafíos de la IA en la práctica cardiovascular. ¡Hazles hueco en tu agenda!
🔗 programa.congresosec.org/@ifdezlozano@rafavidalperez@jvillacastin@mi_cardiologo@belcid7@Martahb5@andreaguala6@NavantiaOficial@Repsol
⚫️ Falece con 90 anos de idade Xosé Manuel Beiras Torrado, nado en Compostela en 1936, unha referencia inescusábel da vida política, social, cultural e académica da Galiza contemporánea
nosdiario.gal/articulo/polit…
🫀 Estenosis aórtica grave y enfermedad coronaria: ¿TAVI o ICP primero? En el ensayo TAVI PCI (986 pacientes, @NEJM), empezar por el TAVI fue no inferior a empezar por la ICP en el objetivo combinado al año (22,2% vs 24,2%).
nejm.org/doi/full/10.1056/NE…#Hemodinamica#TAVI